Abstract:
The present invention provides a pharmaceutical composition comprising a fermented Curcuma longa extract as an active ingredient for preventing or treating gastro-intestinal diseases. The composition of the present invention improves the gastric mucosa protection or alleviates the gastric mucosal damage, and suppresses the inflammatory response in the stomach, thereby has an excellent effect for preventing and treating the gastro-intestinal diseases. The present invention provides a composition and a functional health food comprising the fermented Curcuma longa extract as an active ingredient for preventing or treating the gastro-intestinal diseases.
Abstract:
PURPOSE: A composition for alpha glucosidase activity inhibition is provided to fundamentally reduce the amount of low sugar group which is absorbed into human body. CONSTITUTION: A composition for alpha glucosidase activity inhibition contains Pediococcus sp. JNU 534 (the accession number KCCM-10869P) strain or culture material of the Pediococcus species JNU 534 (the accession number KCCM-10869P) strain. A health supplement contains the composition for the alpha glucosidase activity inhibition. The foods are manufactured into formulations of powder, granule, tablet, capsule or drink medicine A food addition contains the composition for the alpha glucosidase activity inhibition. A fermented milk product contains the composition for the alpha glucosidase activity inhibition. A composition for preventing and treating anti-hyperglycemic contains the composition for the alpha glucosidase activity inhibition as an active ingredient.
Abstract:
본 발명은 불미나리( Oenanthe javanica DC)에서 간세포 보호 및 간 손상 예방 효능을 갖는 카페익산을 추출하는 방법 및 이를 포함하는 기능성 건강식품에 관한 것으로, 본 발명에 의한 불미나리로부터 추출 분리한 카페익산은 간세포 보호 및 간 손상 예방 효능을 갖기 때문에 불미나리 추출물 및 그 카페익산을 함유한 분말류, 음료수, 가공 식품류 등과 같은 기능성 건강지향식품에 유용하게 사용될 수 있다. 불미나리, 카페익산, 간세포, 간 손상, 간 보호, 기능성 식품
Abstract:
The present invention relates to a hypoglycemic composition and, more specifically, to a hypoglycemic composition containing a catechin polymer, manufactured by using a laccase enzyme, as an active component. According to an embodiment of the present invention, a hypoglycemic composition containing a catechin polymer and a method for lowering the blood glucose contents can be implemented.
Abstract:
PURPOSE: A pharmaceutical composition containing a fraction of a Curcuma Longa L. extract for preventing alcoholic liver damage is provided to suppress generation of alcoholic lipid peroxide and to enhance antioxidation. CONSTITUTION: A pharmaceutical composition for preventing alcoholic liver damage contains a fraction of a Curcuma Longa L. water extract as an active ingredient. The fraction is prepared by extracting Curcuma Longa L. with hot water and fractioning with chloroform. The liver damage is alcoholic fatty liver, alcoholic hepatitis, or alcoholic cirrhosis. A health functional food for preventing alcoholic liver damage contains the fraction as an active ingredient.